On average, 7 out of 10 retail investors suffer losses when trading turbo certificates. Turbo certificates are highly risky products and are not suited for long-term investment strategies.
676 - 700 of 89.700
- Product
- Maturity
- Leverage (Omega)
- Sell
- Buy
- Thermo Fisher Scientific Call 670,00 16 Jun 2028
- Goldman Sachs
- 16.06.28
- 2,83x
- Analysis
- Thermo Fisher Scientific Call 590,00 17 Mar 2028
- Goldman Sachs
- 17.03.28
- 2,79x
- Analysis
- Thermo Fisher Scientific Call 690,00 15 Sep 2028
- Goldman Sachs
- 15.09.28
- 2,66x
- Analysis
- Thermo Fisher Scientific Call 570,00 17 Mar 2028
- Goldman Sachs
- 17.03.28
- 2,72x
- Analysis
- Thermo Fisher Scientific Call 630,00 17 Mar 2028
- Goldman Sachs
- 17.03.28
- 2,88x
- Analysis
- Thermo Fisher Scientific Call 670,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 3,75x
- Analysis
- Lam Research Call 335,00 15 Sep 2028
- Goldman Sachs
- 15.09.28
- 1,80x
- Analysis
- Lam Research Call 335,00 16 Jun 2028
- Goldman Sachs
- 16.06.28
- 1,92x
- Analysis
- Lam Research Call 265,00 15 Sep 2028
- Goldman Sachs
- 15.09.28
- 1,68x
- Analysis
- Lam Research Call 315,00 16 Jun 2028
- Goldman Sachs
- 16.06.28
- 1,86x
- Analysis
- Lam Research Call 335,00 17 Mar 2028
- Goldman Sachs
- 17.03.28
- 2,06x
- Analysis
- Adidas Call 135,00 15 Sep 2028
- Goldman Sachs
- 15.09.28
- 2,69x
- Analysis
- Illumina, Inc. Call 200,00 15 Sep 2028
- Goldman Sachs
- 15.09.28
- 1,80x
- Analysis
- Lam Research Call 305,00 16 Jun 2028
- Goldman Sachs
- 16.06.28
- 1,86x
- Analysis
- Lam Research Call 325,00 17 Mar 2028
- Goldman Sachs
- 17.03.28
- 2,02x
- Analysis
- Lam Research Call 315,00 15 Sep 2028
- Goldman Sachs
- 15.09.28
- 1,78x
- Analysis
- Lam Research Call 275,00 15 Sep 2028
- Goldman Sachs
- 15.09.28
- 1,70x
- Analysis
- Lam Research Call 335,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 2,50x
- Analysis
- Danaher Call 205,00 15 Sep 2028
- Goldman Sachs
- 15.09.28
- 2,42x
- Analysis
- Lam Research Call 325,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 2,46x
- Analysis
- Lam Research Call 335,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 2,15x
- Analysis
- Lam Research Call 315,00 17 Mar 2028
- Goldman Sachs
- 17.03.28
- 2,02x
- Analysis
- Pfizer Call 40,00 16 Jun 2028
- Goldman Sachs
- 16.06.28
- 3,90x
- Analysis
- Danaher Call 215,00 15 Sep 2028
- Goldman Sachs
- 15.09.28
- 2,51x
- Analysis
- Lam Research Call 315,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 2,42x
- Analysis